Utilization of Radiotherapy and Stereotactic Body Radiation Therapy for Renal Cell Cancer in the USA
Authors:
- 12 March 2018
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 14 (9) , 819-827
Abstract
Aim: This study evaluated national practice patterns of cT1N0M0 renal cell cancer, with a focus on stereotactic body radiation therapy (SBRT) utilization. Methods: The National Cancer Database was queried (2004–2013) for patients with newly-diagnosed cT1a/bN0M0 renal cell cancer that received definitive treatment. Temporal trends in utilization were tabulated. Results: Altogether, 138,495 patients met inclusion criteria; 13,725 (9.9%) patients received ablative therapy, 57,924 (41.8%) partial nephrectomy, 67,168 (48.5%) radical nephrectomy and 308 (0.2%) external beam radiation therapy (EBRT). The proportion of EBRT that was SBRT increased substantially from 25% in 2004 to 95.4% in 2013, with a sharp inflection point from 2005 to 2006. Conclusion: SBRT utilization has sharply risen over time; in most recent years, the vast majority of EBRT is delivered in the form of SBRT.Keywords
Funding Information
- Elekta AB
- Accuray Inc
This publication has 42 references indexed in Scilit:
- A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinomaBJU International, 2012
- Chronic Kidney Disease After Nephrectomy in Patients with Small Renal Masses: A Retrospective Observational AnalysisEuropean Urology, 2012
- Role of Radiation Therapy in the Management of Renal Cell CancerCancers, 2011
- EAU Guidelines on Renal Cell Carcinoma: The 2010 UpdateEuropean Urology, 2010
- Guideline for Management of the Clinical T1 Renal MassJournal of Urology, 2009
- Cryoablation or radiofrequency ablation of the small renal massCancer, 2008
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidneyActa Oncologica, 2008
- Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort studyThe Lancet Oncology, 2006
- A Randomized Trial of Postoperative Radiotherapy Versus Observation in Stage II and III Renal AdenocarcinomaScandinavian Journal of Urology and Nephrology, 1987